Today on Drug Development Technology
-
Pharma Technology Focus - Issue 13
http://www.drugdevelopment-technology.com/uploads/newsarticle/703852/main.jpgFrom advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new...
-
Dulera (Mometasone Furoate and Formoterol Fumarate Dihydrate) - Treatment for Asthma
http://www.drugdevelopment-technology.com/projects/7219/main.jpgDulera (mometasone furoate and formoterol fumarate dihydrate) is a new fixed-dose combination inhaler for the treatment of...
-
Erwinaze (Asparaginase Erwinia Chrysanthemi) - Treatment for ALL
http://www.drugdevelopment-technology.com/projects/7182/main.jpgErwinaze (asparaginase Erwinia chrysanthemi) is indicated for the treatment of acute lymphoblastic leukaemia (ALL). It is manufactured by EUSA...
-
Surfaxin (Lucinactant) - Treatment for Preventing Infant RDS
http://www.drugdevelopment-technology.com/projects/7171/main.jpgSurfaxin (Lucinactant) is a non-pyrogenic pulmonary surfactant used for the prevention of respiratory distress syndrome (RDS) in premature...
Latest Suppliers
McCarthy Consultant Services Inc.
McCarthy Consultant Services Inc. (MCSI) provides expert regulatory affairs consulting. As a global industry leader, MCSI understands the importance of sound regulatory management and...
McCarthy Consultant Services Inc. (MCSI) provides expert regulatory affairs consulting. As a global industry leader, MCSI understands the importance of sound regulatory management and...
Latest White Papers
Cocrystals in the Pharmaceutical and Fine Chemicals Industry: From an Option to an Opportunity
In the drug discovery and development arena it is well known that the choice of the right solid form can have a dramatic influence on the successful development of an active...
In the drug discovery and development arena it is well known that the choice of the right solid form can have a dramatic influence on the successful development of an active...
Latest News
Scil Proteins, Ono Pharmaceutical enter into drug discovery alliance
Germany-based biotech company, Scil Proteins, has entered into a joint collaboration agreement with Japan's Ono Pharmaceutical for the discovery and development of new Affilin therapeutics to...
Germany-based biotech company, Scil Proteins, has entered into a joint collaboration agreement with Japan's Ono Pharmaceutical for the discovery and development of new Affilin therapeutics to...
Latest Projects
Dulera (Mometasone Furoate and Formoterol Fumarate Dihydrate) - Treatment for Asthma
Dulera (mometasone furoate and formoterol fumarate dihydrate) is a new fixed-dose combination inhaler for the treatment of...
Dulera (mometasone furoate and formoterol fumarate dihydrate) is a new fixed-dose combination inhaler for the treatment of...
Latest Press Releases
Meet Biovian at the Biotech Outsourcing Strategies Conference
Meet Biovian at the Biotech Outsourcing Strategies cmc2012 (BOS cmc) on 14 June 2012 at the Sohuset Conference Center, Denmark. Biovian's director of business development and projects, Dr...
Meet Biovian at the Biotech Outsourcing Strategies cmc2012 (BOS cmc) on 14 June 2012 at the Sohuset Conference Center, Denmark. Biovian's director of business development and projects, Dr...
Latest Features
Pharma Technology Focus - Issue 13
From advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new...
From advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new...
Latest Videos
Eviplera – Treatment for HIV
Eviplera is a single-pill regimen targeted at human immunodeficiency virus-1 (HIV-1). It combines the active substances emtricitabine, rilpivirine and tenofovir disoproxil.
Eviplera is a single-pill regimen targeted at human immunodeficiency virus-1 (HIV-1). It combines the active substances emtricitabine, rilpivirine and tenofovir disoproxil.
